August 01, 2014 5:19 AM ET

Biotechnology

Company Overview of Tapestry Pharmaceuticals, Inc.

Executive Profile

Theodore Friedmann M.D.

Member of the Scientific Advisory Board, Tapestry Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background

Dr. Theodore Friedmann, M.D., is a Professor of Pediatrics and Director of the Gene Therapy Program at the University of California, San Diego. Dr. Friedmann has over 40 years of research experience in the areas of genetics and molecular therapies. He is expertise in Viral Vectors. Dr. Friedmann has been Member of the Scientific Advisory Board of Tapestry Pharmaceuticals (formerly NaPro BioTherapeutics Inc.) since January 12, 2004. Dr. Friedmann serves as Member of Scientific ...

Corporate Headquarters

4840 Pearl East Circle
Boulder, Colorado 80301-2408

United States

Phone: 303-516-8500
Fax: 303-530-1296

Board Members Memberships

There is no Board Members Memberships data available.

Education

MD
The University of Pennsylvania

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tapestry Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.